Giant cell arteritis.
作者信息
Mason J C, Walport M J
出版信息
BMJ. 1992 Jul 11;305(6845):68-9. doi: 10.1136/bmj.305.6845.68.
Abstract
摘要
相似文献
1
Giant cell arteritis.巨细胞动脉炎
BMJ. 1992 Jul 11;305(6845):68-9. doi: 10.1136/bmj.305.6845.68.
2
[Temporal arteritis with giant cells].[伴有巨细胞的颞动脉炎]
Oftalmologia. 2001;52(2):4-11.
3
Diagnosis and management of arteritis.动脉炎的诊断与管理
J R Soc Med. 1994 Nov;87(11):719.
4
[Giant cell arteritis during steroid therapy].[类固醇治疗期间的巨细胞动脉炎]
Ugeskr Laeger. 1988 Aug 29;150(35):2085-6.
5
Duration of treatment after eye involvement in giant cell arteritis.巨细胞动脉炎眼部受累后的治疗持续时间。
J Rheumatol. 2007 Sep;34(9):1945.
6
Steroid treatment in giant cell arteritis.巨细胞动脉炎的类固醇治疗。
Br J Rheumatol. 1992 Jun;31(6):431-2. doi: 10.1093/rheumatology/31.6.431-b.
7
A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.一项为期26周的可行性研究，比较缓释泼尼松与速释泼尼松龙在新诊断的巨细胞动脉炎病例中的疗效和安全性。
Int J Rheum Dis. 2018 Jan;21(1):285-291. doi: 10.1111/1756-185X.13149. Epub 2017 Aug 9.
8
Giant cell arteritis in Mumbai.
J Assoc Physicians India. 2010 Jun;58:372-4.
9
[Therapy of giant cell arteritis].[巨细胞动脉炎的治疗]
Dtsch Med Wochenschr. 1982 Jun 25;107(25):988-9. doi: 10.1055/s-2008-1070061.
10
Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis.在使用泼尼松龙治疗巨细胞动脉炎的18个月期间，第三腰椎的骨矿物质含量。
Clin Rheumatol. 1993 Dec;12(4):455-60. doi: 10.1007/BF02231770.
引用本文的文献
1
Surgical performance for specialties undertaking temportal artery biopsies: who should perform them?进行颞动脉活检的专业科室的手术操作：应由谁来进行？
Br J Ophthalmol. 2002 Feb;86(2):250. doi: 10.1136/bjo.86.2.250.
2
Giant cell arteritis.巨细胞动脉炎
BMJ. 1992 Aug 29;305(6852):524. doi: 10.1136/bmj.305.6852.524-a.
3
Giant cell arteritis.巨细胞动脉炎
BMJ. 1992 Aug 29;305(6852):524. doi: 10.1136/bmj.305.6852.524.
本文引用的文献
1
Presentation of occult giant cell arteritis.隐匿性巨细胞动脉炎的表现。
Arthritis Rheum. 1980 Jun;23(6):641-3. doi: 10.1002/art.1780230605.
2
The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.巨细胞动脉炎（包括颞动脉炎和风湿性多肌痛）的流行病学。不同临床表现和眼部并发症的发病率。
Arthritis Rheum. 1981 Jul;24(7):899-904. doi: 10.1002/art.1780240706.
3
Treatment of polymyalgia rheumatica.
Arthritis Rheum. 1982 Jan;25(1):120. doi: 10.1002/art.1780250124.
4
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.风湿性多肌痛：一项为期10年的流行病学和临床研究。
Ann Intern Med. 1982 Nov;97(5):672-80. doi: 10.7326/0003-4819-97-5-672.
5
Polymyalgia rheumatica and corticosteroids: how much for how long?风湿性多肌痛与皮质类固醇：用量多少及疗程多久？
Ann Rheum Dis. 1983 Aug;42(4):374-8. doi: 10.1136/ard.42.4.374.
6
An arteritis with special reference to polymyalgia arteritica.一种动脉炎，特别提及颞动脉炎。
Acta Pathol Microbiol Scand Suppl. 1973;237:Suppl 237:1-59.
7
Polymyalgia rheumatica. Duration of therapy and long-term outcome.
Am J Med. 1985 Sep;79(3):309-15. doi: 10.1016/0002-9343(85)90309-2.
8
Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985.
Arthritis Rheum. 1988 Jun;31(6):745-9. doi: 10.1002/art.1780310607.
9
Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).风湿性多肌痛和颞动脉炎：预后特征及不同皮质类固醇治疗方案的回顾性分析（对210例患者的11年调查）
Ann Rheum Dis. 1988 Sep;47(9):733-9. doi: 10.1136/ard.47.9.733.
10
Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.
Arthritis Rheum. 1985 Apr;28(4):383-7. doi: 10.1002/art.1780280405.
Zotero 插件